HOSPICES CIVILS DE LYON
Clinical Trials
1.9k
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (989 trials with phase data)• Click on a phase to view related trials
Periodontal Follow-up and Glycemy in Patients With Type 2 Diabetes
- Conditions
- Periodontal Disease
- First Posted Date
- 2025-09-10
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 516
- Registration Number
- NCT07165171
- Locations
- 🇫🇷
Hôpital Charles Foix, Ivry-sur-Seine, France
🇫🇷Centre Hospitalo-Universitaire de Lille, Lille, France
🇫🇷Hospices Civils de Lyon, Centre de Soins Dentaires., Lyon, France
Impact of Mental Health First Aid-trained Peers on the Mental Well-being of First-year Medical Residents. Pilot Study.
- Conditions
- Mental Well-being
- First Posted Date
- 2025-09-08
- Last Posted Date
- 2025-09-08
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 520
- Registration Number
- NCT07161284
- Locations
- 🇫🇷
Service des Urgences Psychiatriques Hôpital Edouard Herriot, GH Centre, Lyon, France, France
Long-term Impact of NMDAR Encephalitis, Level 3
- Conditions
- NMDAR Autoimmune Encephalitis
- First Posted Date
- 2025-09-05
- Last Posted Date
- 2025-09-12
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 30
- Registration Number
- NCT07158229
- Locations
- 🇫🇷
Centre de référence des syndromes neurologies paranéoplasiques et encéphalites auto-immunes - Hôpital neurologiques Pierre WERTHEIMER - Groupement hospitalier Est - Hospices civiles de Lyon, Bron, France
Immunoparalysis After Pancreaticoduodenectomy
- Conditions
- Pancreatic Ductal Adenocarcinoma (mPDAC)Pancreatic Head TumourPancreatic Fistula
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 100
- Registration Number
- NCT07144917
- Locations
- 🇫🇷
Julie PERINEL, Lyon, France
🇫🇷Xavier MULLER, Lyon, France
🇫🇷Aurélien DUPRE, Lyon, France
Tedizolid Neuropathies
- Conditions
- Adult Patients Developing Optic or Peripheral NeuropathyWhile Receiving Tedizolid Therapy Between July 2019 and December 2024
- First Posted Date
- 2025-08-27
- Last Posted Date
- 2025-08-27
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 5
- Registration Number
- NCT07143240
- Locations
- 🇫🇷
HCL, Lyon, France, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 348
- Next
News
Volition's Nu.Q® Cancer Test Shows Promise in Lung Cancer Screening and Pan-Cancer Detection
Volition has enrolled the first patient in a 500-patient validation study at National Taiwan University Hospital to evaluate Nu.Q® Cancer technology for distinguishing between malignant and benign pulmonary nodules in LDCT lung cancer screening.